Hims & Hers Health Inc.(HIMS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

HIMS Hims & Hers Health Inc.

交易中 03-05 13:20:53 EST

15.80

-0.65

-3.98%

最高16.84	最低15.70	成交量1,088万
今开16.53	昨收16.45	日振幅6.93%
总市值35.96亿	流通市值31.20亿	总股本2.28亿
成交额1.76亿	换手率5.51%	流通股本1.98亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"HIMS","market":"US","secType":"STK","nameCN":"Hims & Hers Health Inc.","latestPrice":15.795,"timestamp":1772734852630,"preClose":16.45,"halted":0,"volume":10877786,"delay":0,"changeRate":-0.03981762917933127,"floatShares":197512273,"shares":227648514,"eps":0.512286,"marketStatus":"交易中","change":-0.655,"latestTime":"03-05 13:20:53 EST","open":16.53,"high":16.84,"low":15.7,"amount":176348088.596718,"amplitude":0.069301,"askPrice":15.8,"askSize":320,"bidPrice":15.79,"bidSize":5,"shortable":3,"etf":0,"ttmEps":0.512286,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1772744400000},"marketStatusCode":2,"adr":0,"exchange":"NYSE","adjPreClose":16.45,"preHourTrading":{"tag":"盘前","latestPrice":16.37,"preClose":16.45,"latestTime":"09:29 EST","volume":152132,"amount":2509201.921088,"timestamp":1772720999985,"change":-0.08,"changeRate":-0.004863,"amplitude":0.020061},"postHourTrading":{"tag":"盘后","latestPrice":16.6072,"preClose":16.45,"latestTime":"19:59 EST","volume":408857,"amount":6740089.225,"timestamp":1772672391311,"change":0.1572,"changeRate":0.009556,"amplitude":0.013982},"volumeRatio":0.686811,"optionData":{"bulkOrders":[{"symbol":"HIMS","call":true,"expireDate":1772773200000,"strike":"17.5","timestamp":1772723934695,"price":0.04,"volume":2000,"amount":8000,"type":"-"},{"symbol":"HIMS","call":true,"expireDate":1772773200000,"strike":"17.5","timestamp":1772723873459,"price":0.05,"volume":2000,"amount":10000,"type":"-"}]},"impliedVol":0.9696,"impliedVolPercentile":0.4382},"requestUrl":"/m/hq/s/HIMS","defaultTab":"news","newsList":[{"id":"1109675478","title":"摩根大通减持Hims & Hers Health股份，持股比例从8.1%降至1.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1109675478","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109675478?lang=zh_cn&edition=full","pubTime":"2026-03-06 00:55","pubTimestamp":1772729752,"startTime":"0","endTime":"0","summary":"根据最新提交给美国证券交易委员会（SEC）的文件显示，截至2026年2月27日，摩根大通（JPMorgan Chase & Co.）已将其在远程医疗服务提供商Hims & Hers Health Inc.的持股比例大幅削减至1.7%。这一数据相较于2025年9月30日记录的8.1%持股比例，出现了显著下降。\n此次减持行动反映了摩根大通对Hims & Hers Health投资策略的重大调整。持股比例在不到五个月内下降超过6个百分点，凸显出机构投资者对该股票的看法可能正在发生变化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B1XK9C88.USD","LU0882574139.USD","LU2242649171.HKD","LU0976567544.SGD","LU1720051108.HKD","LU0683600562.USD","LU1116320901.HKD","LU0689472784.USD","LU1988902786.USD","LU1064131342.USD","LU1244550221.USD","IE00B775SV38.USD","HIMZ","BK4588","LU0203345920.USD","LU1145028129.USD","BK4207","LU0211327993.USD","IE0034235188.USD","IE00BKDWB100.SGD","LU0265550359.USD","LU0820562030.AUD","LU0496365809.HKD","LU1670627923.USD","LU2417539215.USD","IE00BYXW3230.USD","LU0320765489.SGD","LU0048584097.USD","LU2357305700.SGD","LU2756315664.SGD","BK4196","LU1162221912.USD","LU2381873111.SGD","LU0943347566.SGD","LU1720051017.SGD","IE000M9KFDE8.USD","LU2456880835.USD","IE0034235295.USD","SG9999002224.SGD","LU1551013342.USD","LU1496350502.SGD","LU1244550494.USD","LU0203347892.USD","LU2430703178.SGD","LU2237443895.HKD","LU1116320737.USD","IE00BHPRN162.USD","IE00BJTD4N35.SGD","LU1280957306.USD","LU2106854487.HKD","LU0106831901.USD","BK4533","LU2552382215.SGD","LU2505996509.AUD","LU0964807845.USD","LU2237443465.HKD","LU2430703095.HKD","LU1914381329.SGD","IE00BDCRKT87.USD","IE00BBT3K403.USD","LU1084165304.USD","BK4566","LU1974910355.USD","IE00BZ1G4Q59.USD","LU2430703251.USD","LU0170899867.USD","LU1917777945.USD","LU0820561818.USD","LU0070302665.USD","LU0149725797.USD","LU0267386448.USD","LU0345770308.USD","IE00BJLML261.HKD","LU0417517546.SGD","LU2237443549.SGD","LU2505996681.GBP","LU0787776722.HKD","JPM","LU0106261372.USD","LU2237443382.USD","HIMS","LU0345769128.USD","LU0211328371.USD","BK4581","IE00BN8TJ469.HKD","LU1261432733.SGD","LU0868494708.USD","LU1119994496.HKD","LU0211326755.USD","LU0971096721.USD","IE0034235303.USD","LU2237443622.USD","LU2592432038.USD","HIMY","LU1032466523.USD","LU0211326839.USD","LU2264538146.SGD","LU1363072403.SGD","LU2211815571.USD","LU2756315318.SGD","LU2236285917.USD","IE00BLSP4239.USD","IE00BFXG1179.USD","IE00BKVL7J92.USD","LU0345769631.USD","LU1548497426.USD","LU1894683264.USD","LU2023250843.SGD","BK4550","BK4534","LU1668664300.SGD","LU2746668461.USD","LU0868494617.USD","HMYY","JPMO","LU0208291251.USD","HIYY","LU0323591593.USD","BK4504","LU1894683348.USD","IE00B3S45H60.SGD","LU0820561909.HKD","LU0942090050.USD","LU0211331839.USD","IE00BLSP4452.SGD","LU2552382058.USD","LU1244550577.SGD","LU0215105999.USD","LU1267930490.SGD","LU0310799852.SGD","LU2023250330.USD","IE00B1BXHZ80.USD","LU0265550946.USD","LU2746668974.SGD","LU0234572021.USD","LU0251132253.USD","IE00BJTD4V19.USD","LU0640476718.USD","LU2237443978.SGD","SG9999002232.USD","IE00BDRTCR15.USD","LU0320765646.SGD","LU0006306889.USD","BK4516","LU2552382132.HKD","LU1496350171.SGD","BK4585","LU2054465674.USD","LU2213496289.HKD","LU1551013425.SGD","LU0256863811.USD","LU0238689110.USD","LU2462157665.USD","LU1629891620.HKD","LU0345770993.USD","LU2023250504.SGD","LU1670628061.USD","LU1366192091.USD","IE00BWXC8680.SGD"],"gpt_icon":0},{"id":"1131291975","title":"异动解读 | Hims & Hers Health盘中大跌10.61%，业绩指引不及预期与监管不确定性双重打击","url":"https://stock-news.laohu8.com/highlight/detail?id=1131291975","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131291975?lang=zh_cn&edition=full","pubTime":"2026-02-24 22:46","pubTimestamp":1771944400,"startTime":"0","endTime":"0","summary":"远程医疗公司Hims & Hers Health Inc.今日盘中股价大跌10.61%，引发了市场广泛关注。消息面上，公司此前公布的2026年第一季度营收指引显著低于市场预期，是导致股价承压的直接原因。根据公司财报，其预计第一季度营收介于6亿至6.25亿美元之间，远低于市场预期的6.5312亿美元。同时，公司给出的2026财年全年收入指引也低于分析师预期。此外，监管层面的不确定性进一步加剧了投资者的担忧。多家券商因此下调了该股的目标价，并指出其GLP-1业务存在显著不确定性。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0fffc80212931f337b90385d4073028f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HIMS"],"gpt_icon":0},{"id":"2613103007","title":"美股异动 | Q4营收低于预期 Hims & Hers Health(HIMS.US)盘前跌超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613103007","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613103007?lang=zh_cn&edition=full","pubTime":"2026-02-24 22:23","pubTimestamp":1771942999,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周二，Hims & Hers Health盘前跌超7%，报14.40美元。消息面上，该公司2025年第四季度营收6.1782亿美元，同比增长28%，但低于预期的6.1922亿;每股收益0.08美元，超出预期的0.03。订阅用户数超过250万人，毛利率从一年前的77%收窄至72%。该公司预计第一季度营收介于6亿至6.25亿之间，低于预期的6.5312亿，并预计2026财年全年收入介于27亿至29亿之间，而市场预期为27.4亿。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":"0fffc80212931f337b90385d4073028f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1406876.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["HIMS","BK4196","BK4535","SRTY","RWM","BK4550","HIYY","HIMY","IWO","UWM","TWM","HIMZ","MNQmain","BK4585","BK4534","BK4581","BK4588","HMYY","TNA","TZA","IWN"],"gpt_icon":0},{"id":"1173861631","title":"异动解读 | Hims & Hers Health盘前大跌7.16%，营收指引不及预期与监管不确定性双重打击","url":"https://stock-news.laohu8.com/highlight/detail?id=1173861631","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173861631?lang=zh_cn&edition=full","pubTime":"2026-02-24 17:07","pubTimestamp":1771924029,"startTime":"0","endTime":"0","summary":"远程医疗服务提供商Hims & Hers Health Inc.今日盘前股价大幅下跌7.16%，引发了市场广泛关注。消息面上，公司公布的2025年第四季度营收虽同比增长28%，但其给出的2026年第一季度营收指引仅为6亿至6.25亿美元，低于市场普遍预期的6.5259亿美元，这一令人失望的业绩展望是导致股价承压的主要原因。Hims & Hers Health的减重业务是其关键增长领域，任何潜在的监管变化都可能影响公司未来营收。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0fffc80212931f337b90385d4073028f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HIMS"],"gpt_icon":0},{"id":"2613560764","title":"Hims & Hers Health第四季度销售额增长，但对第一季度业绩预期偏低","url":"https://stock-news.laohu8.com/highlight/detail?id=2613560764","media":"新浪财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613560764?lang=zh_cn&edition=full","pubTime":"2026-02-24 13:54","pubTimestamp":1771912452,"startTime":"0","endTime":"0","summary":"这份财报发布之际，Hims & Hers正面临诺和诺德提起的诉讼，后者要求禁止该公司销售其减重药物的仿制品。诺和诺德指控Hims & Hers侵犯司美格鲁肽相关专利，而Hims & Hers则批评该诉讼是在打压平价药物选择。Hims & Hers的减重业务是其发展关键。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224135638a7188754&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224135638a7188754&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HIYY","HIMY","HIMZ","BK4196","HMYY","HIMS"],"gpt_icon":1},{"id":"1166733309","title":"美股夜盘 | Vir Biotechnology涨超57%，公司宣布多项重磅利好；Hims & Hers Health跌超8%，Q1营收指引令人失望","url":"https://stock-news.laohu8.com/highlight/detail?id=1166733309","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166733309?lang=zh_cn&edition=full","pubTime":"2026-02-24 09:05","pubTimestamp":1771895104,"startTime":"0","endTime":"0","summary":"2月24日，美股夜盘时段，Vir Biotechnology涨超57%，Q4营收同比增长417%，并宣布VIR-5500的1期临床试验取得积极结果；Hims & Hers Health跌超8%，Q4营收同比增长28%，2026年Q1营收指引令人失望。","market":"us","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0fffc80212931f337b90385d4073028f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VIR","HIMS"],"gpt_icon":0},{"id":"1124149683","title":"异动解读 | Hims & Hers Health夜盘大跌7.35%，营收指引不及预期与监管不确定性双重施压","url":"https://stock-news.laohu8.com/highlight/detail?id=1124149683","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124149683?lang=zh_cn&edition=full","pubTime":"2026-02-24 09:02","pubTimestamp":1771894968,"startTime":"0","endTime":"0","summary":"远程医疗服务提供商Hims & Hers Health Inc.今日夜盘股价大幅下跌7.35%，引发了市场广泛关注。消息面上，公司最新公布的2025年第四季度营收虽然同比增长28%至6.178亿美元，但其给出的2026年第一季度营收指引仅为6.00亿至6.25亿美元，低于市场普遍预期的6.5259亿美元，这一令人失望的业绩展望是导致股价承压的主要原因。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0fffc80212931f337b90385d4073028f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HIMS"],"gpt_icon":0},{"id":"1121451175","title":"Hims & Hers Q4营收同比增长28%，2026年Q1营收指引令人失望","url":"https://stock-news.laohu8.com/highlight/detail?id=1121451175","media":"老虎资讯综合","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121451175?lang=zh_cn&edition=full","pubTime":"2026-02-24 06:59","pubTimestamp":1771887557,"startTime":"0","endTime":"0","summary":"2月24日，Hims & Hers Health盘后跌超6%！尽管在 2025 年第四季度财务业绩中营收超出预期，但其 2026 年第一季度营收预期低于市场普遍预期。2026年全年营收预计为27亿至29亿美元，市场普遍预期为27.1亿美元。Hims & Hers Health 本季度营收同比增长约 28%，达到约 6.178 亿美元，这为其业绩增长提供了助力。截至 2025 年底，该公司持有现金、现金等价物和短期可供出售投资 4.492 亿美元，而截至 2024 年 12 月 31 日约为 3.003 亿美元。","market":"us","thumbnail":"https://static.tigerbbs.com/60f0c533493e9fa6fdd468f321c591b6","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/60f0c533493e9fa6fdd468f321c591b6"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0fffc80212931f337b90385d4073028f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Hims & Hers Q4营收同比增长28%，2026年Q1营收指引令人失望","news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS"],"gpt_icon":0},{"id":"1188410247","title":"异动解读 | 监管不确定性引发担忧，Hims & Hers Health盘后大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=1188410247","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188410247?lang=zh_cn&edition=full","pubTime":"2026-02-24 06:45","pubTimestamp":1771886726,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc.（股票代码：HIMS）今日盘后股价大幅下跌5.09%，引起了市场的关注。消息面上，根据公司提交给美国证券交易委员会（SEC）的文件显示，目前尚不清楚美国食品和药物监督管理局（FDA）、美国卫生与公众服务部（HHS）或司法部（DOJ）可能对复合GLP-1产品的营销采取何种监管行动。这一监管不确定性引发了投资者的担忧，可能是导致股价下跌的主要原因。复合GLP-1产品是Hims & Hers Health业务的重要组成部分，任何潜在的监管变化都可能对公司未来的营收和增长前景产生影响。市场正在密切关注相关监管机构的后续动向。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0fffc80212931f337b90385d4073028f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HIMS"],"gpt_icon":0},{"id":"1131573891","title":"Hims & Hers Health：SEC文件称，目前尚不清楚FDA、HHS或司法部将对复合GLP-1产品的营销采取何种行动","url":"https://stock-news.laohu8.com/highlight/detail?id=1131573891","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131573891?lang=zh_cn&edition=full","pubTime":"2026-02-24 06:34","pubTimestamp":1771886088,"startTime":"0","endTime":"0","summary":"根据Hims & Hers Health Inc.提交给美国证券交易委员会（SEC）的文件，目前尚不清楚美国食品和药物监督管理局（FDA）、美国卫生与公众服务部（HHS）或司法部（DOJ）可能对复合GLP-1产品的营销采取何种监管行动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","HIYY","HIMS","HMYY","HIMZ","HIMY"],"gpt_icon":0},{"id":"1157956458","title":"异动解读 | Hims & Hers盘前大涨9.22%，因宣布以最高11.5亿美元收购澳大利亚数字健康公司Eucalyptus","url":"https://stock-news.laohu8.com/highlight/detail?id=1157956458","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157956458?lang=zh_cn&edition=full","pubTime":"2026-02-19 21:04","pubTimestamp":1771506296,"startTime":"0","endTime":"0","summary":"远程医疗服务提供商Hims & Hers Health Inc. 今日盘前股价大幅上涨9.22%，引起了市场的广泛关注。消息面上，该公司宣布已达成协议，将以现金加股票的方式收购澳大利亚领先的数字健康服务商Eucalyptus，交易价值最高可达11.5亿美元。根据交易条款，Hims & Hers将在交易完成时支付约2.4亿美元现金，其余部分将以递延付款和与业绩挂钩的方式支付。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4ac6d4a053661557ed9e2864eddf2f28","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HIMS"],"gpt_icon":0},{"id":"1179155456","title":"Hims & Hers Health将以最高11.5亿美元收购澳大利亚Eucalyptus公司","url":"https://stock-news.laohu8.com/highlight/detail?id=1179155456","media":"老虎资讯综合","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179155456?lang=zh_cn&edition=full","pubTime":"2026-02-19 19:59","pubTimestamp":1771502354,"startTime":"0","endTime":"0","summary":"Hims & Hers Health周四宣布，将以最高11.5亿美元的交易价值收购澳大利亚数字健康公司Eucalyptus。据Hims & Hers介绍，Eucalyptus在全球运营多个面向消费者的品牌，包括减肥项目Juniper和男性远程医疗品牌Pilot，已服务超过77.5万名客户。Hims & Hers目前正面临丹麦制药商诺和诺德的诉讼。Hims & Hers表示，收购完成时将以现金支付约2.4亿美元。Hims & Hers盘前升逾6%。","market":"us","thumbnail":"https://community-static.tradeup.com/news/aeff3291ebf89b4170f4961d08caf7e6","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/aeff3291ebf89b4170f4961d08caf7e6"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4ac6d4a053661557ed9e2864eddf2f28","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Hims & Hers Health将以最高11.5亿美元收购澳大利亚Eucalyptus公司","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS"],"gpt_icon":1},{"id":"1198564450","title":"Hims & Hers宣布收购Eucalyptus协议，加速其成为全球领先消费健康平台的愿景","url":"https://stock-news.laohu8.com/highlight/detail?id=1198564450","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198564450?lang=zh_cn&edition=full","pubTime":"2026-02-19 19:03","pubTimestamp":1771499021,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc. 已正式宣布达成收购Eucalyptus的协议，此举将显著推动公司实现其战略目标——打造全球首屈一指的消费健康平台。通过本次收购，Hims & Hers旨在整合资源，扩大市场份额，并加速其在全球健康服务领域的布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4ac6d4a053661557ed9e2864eddf2f28","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS","HIMZ","BK4196","HIMY","HMYY"],"gpt_icon":0},{"id":"1170642269","title":"Hims & Hers Health收购方案：包含担保递延付款及与2029年初财务目标挂钩的盈利支付计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1170642269","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170642269?lang=zh_cn&edition=full","pubTime":"2026-02-19 19:03","pubTimestamp":1771499010,"startTime":"0","endTime":"0","summary":"远程医疗服务提供商Hims & Hers Health Inc.近期披露的收购条款显示，交易对价结构包含多重财务安排。根据协议条款，收购方将提供有担保的递延付款方案，同时设置与标的公司业绩表现直接关联的盈利支付机制。\n该盈利支付条款的有效期将延续至2029年初，其支付额度与标的公司在约定期间内达成特定财务指标的完成度直接挂钩。这种对价设计既保障了交易基础价值的实现，又为收购方控制投资风险提供了弹性空间。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4ac6d4a053661557ed9e2864eddf2f28","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS","HIMZ","BK4196","HIMY","HMYY"],"gpt_icon":0},{"id":"1162245690","title":"Hims & Hers Health Inc.：计划主要利用手头现金及美国业务未来经营现金流为交易提供资金","url":"https://stock-news.laohu8.com/highlight/detail?id=1162245690","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162245690?lang=zh_cn&edition=full","pubTime":"2026-02-19 19:02","pubTimestamp":1771498954,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc. 表示，已准备好主要通过公司现有的手头现金以及其美国业务未来产生的经营现金流，来为潜在的交易提供资金支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMZ","BK4196","HIMS","HIMY","HMYY"],"gpt_icon":0},{"id":"1120748101","title":"财报前瞻｜Hims & Hers Health Inc.本季营收预计增31.66%，机构观点偏谨慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1120748101","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120748101?lang=zh_cn&edition=full","pubTime":"2026-02-16 10:45","pubTimestamp":1771209914,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc.将于2026年02月23日美股盘后发布财报，市场普遍聚焦营收增速、利润弹性与GLP-1相关合规变动对短期表现的影响。市场一致预期显示，本季度Hims & Hers Health Inc.营收预计为6.19亿美元，同比增长31.66%；调整后每股收益预计为0.03美元，同比下降68.47%；息税前利润预计为1,196.29万美元，同比下降57.58%；我们收集的数据未披露本季度毛利率与净利润或净利率的明确预测，公司层面的季度指引也未见公开信息。近期机构观点以谨慎与看空为主导。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻｜Hims & Hers Health Inc.本季营收预计增31.66%，机构观点偏谨慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS"],"gpt_icon":1},{"id":"2610781009","title":"诺和诺德起诉Hims 监管机构关注复方GLP1药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2610781009","media":"环球市场播报","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610781009?lang=zh_cn&edition=full","pubTime":"2026-02-12 23:49","pubTimestamp":1770911340,"startTime":"0","endTime":"0","summary":"诺和诺德（NVO）周四早盘上涨1%。该公司提起诉讼，要求阻止Hims & Hers （HIMS） 销售复方司美格鲁肽，数日前美国食品药品监督管理局与卫生及公共服务部暗示将采取执法行动。Hims暂停口服制剂供应，周四早盘该股股价下跌1.5%。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-02-12/doc-inhmqrvx6597100.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4599","BK4532","BK4007","NVO","NVOH","LU1093756325.SGD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU0154236417.USD","HIMS","BK4585","LU1093756168.USD","NVOX","BK4588"],"gpt_icon":0},{"id":"1188992537","title":"异动解读 | 诺和诺德提起专利诉讼，Hims & Hers Health盘中大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1188992537","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188992537?lang=zh_cn&edition=full","pubTime":"2026-02-10 23:24","pubTimestamp":1770737094,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc.  今日盘中股价大幅下跌5.10%，引起了市场的广泛关注。消息面上，此次股价波动主要与丹麦制药巨头诺和诺德对其提起的专利侵权诉讼有关。诺和诺德周一提起诉讼，指控Hims公司销售其减肥药Wegovy的仿制品，侵犯了其专利权。这起诉讼标志着诺和诺德在打击其重磅药物仿制品方面开辟了新战线。分析指出，专利诉讼通常耗时较长且可能导致高额赔偿，这引发了市场对Hims公司潜在法律风险及未来业务发展的担忧，从而打压了股价。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HIMS"],"gpt_icon":0},{"id":"2610651923","title":"Hims撤销Wegovy仿制计划 股价暴跌26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610651923","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610651923?lang=zh_cn&edition=full","pubTime":"2026-02-09 23:01","pubTimestamp":1770649260,"startTime":"0","endTime":"0","summary":"Hims & Hers（HIMS）周一早盘暴跌26.2%。鉴于FDA审查及法律风险，该公司已取消销售复合司美格鲁肽药片计划，诺和诺德（NVO）股价上涨。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-02-09/doc-inhmfumc9074317.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1093756168.USD","BK4532","BK4599","LU1093756325.SGD","NVOH","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU0154236417.USD","BK4585","HIMS","NVO","NVOX","BK4007","BK4196","BK4588","SINA"],"gpt_icon":0},{"id":"2610659393","title":"美股低开 减肥药概念股普涨 诺和诺德涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610659393","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610659393?lang=zh_cn&edition=full","pubTime":"2026-02-09 22:32","pubTimestamp":1770647542,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IWN","BK4535","BK4588","MNQmain","HIMS","LU1093756325.SGD","SRTY","TZA","UWM","BK4599","LU1093756168.USD","IWO","LLY","BK4585","NVOX","IE00BKVL7J92.USD","LU0154236417.USD","TWM","BK4581","RWM","IE00BZ1G4Q59.USD","BK4550","NVO","TNA","BK4532","BK4534","NVOH","BK4007"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0398},{"period":"1month","weight":-0.3778},{"period":"3month","weight":-0.589},{"period":"6month","weight":-0.6602},{"period":"1year","weight":-0.5937},{"period":"ytd","weight":-0.4934}],"compareEarnings":[{"period":"1week","weight":-0.0116},{"period":"1month","weight":-0.0148},{"period":"3month","weight":0.0011},{"period":"6month","weight":0.0585},{"period":"1year","weight":0.1877},{"period":"ytd","weight":0.0047}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Hims & Hers Health Inc是一家多专业远程医疗平台，将消费者与持牌医疗保健专业人员联系起来，使他们能够获得与心理健康、性健康、皮肤病学、头发护理等相关的多种疾病的高质量医疗服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.098962},{"month":2,"riseRate":0.571429,"avgChangeRate":0.066017},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.031403},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.029824},{"month":5,"riseRate":0.5,"avgChangeRate":0.191652},{"month":6,"riseRate":0.666667,"avgChangeRate":-0.021115},{"month":7,"riseRate":0.666667,"avgChangeRate":0.073238},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.14623},{"month":9,"riseRate":0.5,"avgChangeRate":0.080437},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.073266},{"month":11,"riseRate":0.714286,"avgChangeRate":0.187933},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.001486}],"exchange":"NYSE","name":"Hims & Hers Health Inc.","nameEN":"Hims & Hers Health Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Hims & Hers Health Inc.(HIMS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Hims & Hers Health Inc.(HIMS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Hims & Hers Health Inc.,HIMS,Hims & Hers Health Inc.股票,Hims & Hers Health Inc.股票老虎,Hims & Hers Health Inc.股票老虎国际,Hims & Hers Health Inc.行情,Hims & Hers Health Inc.股票行情,Hims & Hers Health Inc.股价,Hims & Hers Health Inc.股市,Hims & Hers Health Inc.股票价格,Hims & Hers Health Inc.股票交易,Hims & Hers Health Inc.股票购买,Hims & Hers Health Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Hims & Hers Health Inc.(HIMS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Hims & Hers Health Inc.(HIMS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}